Welcome to the 4th annual ‘Howard’s Way Walk’ - The Dales Way

Howard’s Way walk gathered like-minded people to take a 3-day stroll to raise money for Pancreatic Cancer research, and we're very proud to say that all the walkers completed the 84 mile walk.

Photo Exhibition

Click here for photographs

In 2007 the resilient Howard Kerr was diagnosed with pancreatic cancer. Howard decided to raise money to fight the disease that sadly he would eventually succumb to, by walking large distances with friends.

Each year, around 7,000 men and women in the UK are diagnosed with pancreatic cancer, a cancer that has the lowest survival rate of all cancers, with an average survival time after diagnosis of just six months. Howard knew that this cancer was a killer and he wanted to help fight it long after he passed - so he created Howard’s Way Walk.

As a direct consequence of the efforts of all involved the first Howard Kerr PHD Studentship Award has been granted to a student studying at the Institute of Cancer at Barts.The studentship is directed at finding ways to detect pancreatic cancer at an early stage via proteins in the body.

That makes us sound like a bunch of amblers who like nothing more than fresh air and countryside - but we have to admit that’s not true.

Most of us work in the media industry; so that’s the fresh air out the window, and the closest we get to the countryside is playing remedial sports or lounging in the garden with a drink.

Let's be honest, the only serious part of our walk is the cause we raise money for.

To date the Kerr PHD Studentship research has shown that there is a molecule on the surface of most pancreatic cancer cells, called alpha-v beta-6 (called avb6), that is not expressed on normal pancreatic cells nor on most other normal tissues.

The Howard Kerr PhD Studentship Award has allowed them to confirm that the presence of avb6 gives pancreatic cells the ability to move, to invade and to grow better, all of which contributes to the severity of pancreatic cancer.

The studentship is therefore developing methods to block the ability of avb6 to function properly, so that we can stop avb6 promoting pancreatic cancer growth and spread.